| General Information of This Metabolic Reaction (MR) (ID:
MR006382) |
| Formula |
|
| Reactant |
NSC-122758 |
Product |
5,6-Epoxyretinoic acid |
|
Reactant Info
|
Product Info
|
|
Metabolic Enzyme
|
Lauric acid omega-hydroxylase (CYP4A11)
|
DME Info
|
|
Cytochrome P450 3A5 (CYP3A5)
|
DME Info
|
|
Cytochrome P450 2C8 (CYP2C8)
|
DME Info
|
|
|
|
|
|
|
|
| Other MR(s) Related to The Reactant of This MR |
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
|
| Other MR(s) Related to The Product of This MR |
|
Other MR(s) That Produce The Product of This MR
|
|
|
|
Other MR(s) That Metabolize The Produtc of This MR
|
|
|
| References |
| 1 |
Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol. 2000 Dec;58(6):1341-8.
|
| 2 |
CYP26C1 is a hydroxylase of multiple active retinoids and interacts with cellular retinoic acid binding proteins. Mol Pharmacol. 2018 May;93(5):489-503.
|
| 3 |
Retinoic acid metabolism and mechanism of action: a review
|
| 4 |
Clinical pharmacokinetics of tretinoin
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.